Commonwealth legislation

National Health Special Arrangement Revocation Instrument 2012 (No. PB 23 of 2012)

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

1/10 complexity

This instrument cancels two special government programs that provided subsidized access to specific medicines under the Pharmaceutical Benefits Scheme (PBS).

What it does:

Revokes (cancels) the National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011, which governed access to chemotherapy drugs
Revokes (cancels) the National Health (Trastuzumab) Special Arrangement 2011, which governed access to trastuzumab (a medicine used to treat certain cancers, also known as Herceptin)

Who it affects: Patients who were receiving these specific medicines through the 2011 special arrangements, as well as doctors and pharmacists who administered them.

Why it matters: When these arrangements are revoked, patients may no longer access these medicines under the special 2011 rules. They would typically transition to standard PBS arrangements or alternative funding pathways. This is a housekeeping measure to end temporary or superseded access programs.

JSON API Health / NDIS / medicines

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in National Health Special Arrangement Revocation Instrument 2012 (No. PB 23 of 2012).

National Health Special Arrangement Revocation Instrument 2012 (No. PB 23 of 2012)

View image in the official source

PB 23 of 2012

National Health Special Arrangement Revocation Instrument 20121

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this instrument under subsection 100 (2) of the National Health Act 1953.

Dated 27 March 2012

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

1 Name of Instrument

(1) This instrument is the National Health Special Arrangement

Revocation Instrument 2012.

(2) This instrument may also be cited as PB 23 of 2012.

2 Commencement

This instrument commences on 1 April 2012.

3 Revocation

The following legislative instruments are revoked:

(1) National Health (Chemotherapy Pharmaceuticals Access Program)

Special Arrangement 2011 (PB 87 of 2011)

(2) National Health (Trastuzumab) Special Arrangement 2011 (PB 94 of

Note

Note: 1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 National Health Special Arrangement Revocation Instrument 2012 (No. PB 23 of 2012)